John Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John Miller has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- David G. Armstrong
Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
8 shared publications - Nicholas A. Giovinco
Southern Arizona Limb Salvage Alliance (SALSA), Department of Surgery, University of Arizona College of Medicine, Tucson, AZ, USA
8 shared publications - Joseph L. Mills
Baylor College of Medicine
5 shared publications David G. Armstrong
4 shared publications- Bijan Najafi
Center for Advanced Surgical & Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA
3 shared publications Timothy M. Rankin
Department of General Surgery, University of Arizona, Tucson, AZ, USA
3 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in Annals of Vascular Surgery - Brief Reports and Innovations
- Vol. 6 (4)
An algorithmic approach to the final stage of a functional amputation in the staged below-the-knee amputation with targeted muscle reinnervation: Case series and surgical technique
- 26 October 2026
- Published by Elsevier in Annals of Vascular Surgery - Brief Reports and Innovations
- Vol. 6 (4)
Open AccessAn algorithmic approach to the final stage of a functional amputation in the staged below-the-knee amputation with targeted muscle reinnervation: Case series and surgical technique
- 1 September 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 61 (5) , 964-968
Safety of Tibial Half Pins With Circular External Fixation for Foot and Ankle Reconstruction in Patients With Peripheral Neuropathy
- 1 September 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 61 (5) , 964-968
Safety of Tibial Half Pins With Circular External Fixation for Foot and Ankle Reconstruction in Patients With Peripheral Neuropathy
- 1 January 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1083) , 20170374
Image once, print thrice? Three-dimensional printing of replacement parts
Objective: The last 20 years has seen an exponential increase in 3D printing as it pertains to the medical industry and more specifically surgery. Previous reviews in this domain have chosen to focus on applications within a specific field. To our knowledge, none have evaluated the broad applications of patient-specific or digital imaging and communications in medicine (DICOM) derived applications of this technology. Methods: We searched PUBMED and CINAHL from April 2012 to April 2017. Results: 261 studies fulfilled the inclusion criteria. Proportions of articles reviewed: DICOM (5%), CT (38%), MRI (20%), Ultrasonography (28%), and Bio-printing (9%). Conclusion: There is level IV evidence to support the use of 3D printing for education, pre-operative planning, simulation and implantation. In order to make this technology widely applicable, it will require automation of DICOM to standard tessellation language to implant. Advances in knowledge: Recent lapses in intellectual property and greater familiarity with rapid prototyping in medicine has set the stage for the next generation of custom implants, simulators and autografts. Radiologists may be able to help establish reimbursable procedural terminology.
- 1 January 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1083) , 20170374
Image once, print thrice? Three-dimensional printing of replacement parts
Objective: The last 20 years has seen an exponential increase in 3D printing as it pertains to the medical industry and more specifically surgery. Previous reviews in this domain have chosen to focus on applications within a specific field. To our knowledge, none have evaluated the broad applications of patient-specific or digital imaging and communications in medicine (DICOM) derived applications of this technology. Methods: We searched PUBMED and CINAHL from April 2012 to April 2017. Results: 261 studies fulfilled the inclusion criteria. Proportions of articles reviewed: DICOM (5%), CT (38%), MRI (20%), Ultrasonography (28%), and Bio-printing (9%). Conclusion: There is level IV evidence to support the use of 3D printing for education, pre-operative planning, simulation and implantation. In order to make this technology widely applicable, it will require automation of DICOM to standard tessellation language to implant. Advances in knowledge: Recent lapses in intellectual property and greater familiarity with rapid prototyping in medicine has set the stage for the next generation of custom implants, simulators and autografts. Radiologists may be able to help establish reimbursable procedural terminology.
- 16 November 2017
- Published by S. Karger AG
- Vol. 26, 210-218
Towards Extending Ulcer-Free Days in Remission in the Diabetic Foot Syndrome
Management of the diabetic foot is multifaceted and requires constant monitoring from patients and health care providers. The alarmingly high rates of diabetic foot ulcer recurrence are an indication for a change that we need to bring about in our approach to care and to the use of vernacular in the medical literature. With its high rates of morbidity and recidivism, care of the complex diabetic foot may be aptly comparable to many forms of cancer. Therefore, our efforts should be not only to achieve rapid healing of open wounds but also to maximize the number of ulcer-free days for the patient in diabetic foot remission. Novel approaches in surgical techniques and advances in wearable technology appear to show promise in measuring inflammation and modulating dangerous pressures to extend remission and improve quality of life for these most complex patients.
- 16 November 2017
- Published by S. Karger AG
- Vol. 26, 210-218
Towards Extending Ulcer-Free Days in Remission in the Diabetic Foot Syndrome
Management of the diabetic foot is multifaceted and requires constant monitoring from patients and health care providers. The alarmingly high rates of diabetic foot ulcer recurrence are an indication for a change that we need to bring about in our approach to care and to the use of vernacular in the medical literature. With its high rates of morbidity and recidivism, care of the complex diabetic foot may be aptly comparable to many forms of cancer. Therefore, our efforts should be not only to achieve rapid healing of open wounds but also to maximize the number of ulcer-free days for the patient in diabetic foot remission. Novel approaches in surgical techniques and advances in wearable technology appear to show promise in measuring inflammation and modulating dangerous pressures to extend remission and improve quality of life for these most complex patients.
- 9 July 2015
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 4 (3) , 249-256
Current Standards and Advances in Diabetic Ulcer Prevention and Elderly Fall Prevention Using Wearable Technology
- 9 July 2015
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 4 (3) , 249-256
Current Standards and Advances in Diabetic Ulcer Prevention and Elderly Fall Prevention Using Wearable Technology
- Open Access
- 8 June 2015
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 9 (4) , 873-880
Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration
The US diabetic foot ulcer (DFU) incidence is 3-4% of 22.3 million diagnosed diabetes cases plus 6.3 million undiagnosed, 858 000 cases total. Risk of recurrence after healing is 30% annually. Lower extremity multiple nerve decompression (ND) surgery reduces neuropathic DFU (nDFU) recurrence risk by >80%. Cost effectiveness of hypothetical ND implementation to minimize nDFU recurrence is compared to the current $6.171 billion annual nDFU expense. A literature review identified best estimates of annual incidence, recurrence risk, medical management expense, and noneconomic costs for DFU. Illustrative cost/benefit calculations were performed assuming widespread application of bilateral ND after wound healing to the nDFU problem, using Center for Medicare Services mean expense data of $1143/case for unilateral lower extremity ND. Calculations use conservative, evidence-based cost figures, which are contemporary (2012) or adjusted for inflation. Widespread adoption of ND after nDFU healing could reduce annual DFU occurrences by at least 21% in the third year and 24% by year 5, representing calculated cost savings of $1.296 billion (year 3) to $1.481 billion (year 5). This scenario proffers significant expense reduction and societal benefit, and represents a minimum 1.9× return on the investment cost for surgical treatment. Further large cost savings would require reductions in initial DFU incidence, which ND might achieve by selective application to advanced diabetic sensorimotor polyneuropathy (DSPN). By minimizing the contribution of recurrences to yearly nDFU incidence, ND has potential to reduce by nearly $1 billion the annual cost of DFU treatment in the United States.
- 8 June 2015
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 9 (4) , 873-880
Open AccessIllustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration
The US diabetic foot ulcer (DFU) incidence is 3-4% of 22.3 million diagnosed diabetes cases plus 6.3 million undiagnosed, 858 000 cases total. Risk of recurrence after healing is 30% annually. Lower extremity multiple nerve decompression (ND) surgery reduces neuropathic DFU (nDFU) recurrence risk by >80%. Cost effectiveness of hypothetical ND implementation to minimize nDFU recurrence is compared to the current $6.171 billion annual nDFU expense. A literature review identified best estimates of annual incidence, recurrence risk, medical management expense, and noneconomic costs for DFU. Illustrative cost/benefit calculations were performed assuming widespread application of bilateral ND after wound healing to the nDFU problem, using Center for Medicare Services mean expense data of $1143/case for unilateral lower extremity ND. Calculations use conservative, evidence-based cost figures, which are contemporary (2012) or adjusted for inflation. Widespread adoption of ND after nDFU healing could reduce annual DFU occurrences by at least 21% in the third year and 24% by year 5, representing calculated cost savings of $1.296 billion (year 3) to $1.481 billion (year 5). This scenario proffers significant expense reduction and societal benefit, and represents a minimum 1.9× return on the investment cost for surgical treatment. Further large cost savings would require reductions in initial DFU incidence, which ND might achieve by selective application to advanced diabetic sensorimotor polyneuropathy (DSPN). By minimizing the contribution of recurrences to yearly nDFU incidence, ND has potential to reduce by nearly $1 billion the annual cost of DFU treatment in the United States.
- 1 May 2015
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 54 (3) , 382-391
A Passing Glance? Differences in Eye Tracking and Gaze Patterns Between Trainees and Experts Reading Plain Film Bunion Radiographs
- 1 May 2015
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 54 (3) , 382-391
A Passing Glance? Differences in Eye Tracking and Gaze Patterns Between Trainees and Experts Reading Plain Film Bunion Radiographs
- Open Access
- 27 January 2015
- Published by Taylor & Francis in Diabetic Foot & Ankle
- Vol. 6 (1) , 24999
Use of collagenase ointment in conjunction with negative pressure wound therapy in the care of diabetic wounds: a case series of six patients
BackgroundDiabetic wounds with additional comorbidities are costly, time intensive, and difficult to heal. Often, multiple modalities may be necessary to achieve wound resolution, relying on the synergistic advantage of each therapy to affect wound healing. The selectivity of Clostridium collagenase is physiologically effective at degrading non-viable collagen fibers while preserving living collagen tissue. Additionally, negative pressure wound therapy (NPWT) has long been used to aid wound healing while concurrently depreciating biological wound burden time.MethodsSix patients were selected from those appearing to our university based limb salvage service. Inclusion criteria included patients with a recurrent mixed fibrotic and granular wound base, in which NPWT was indicated, without exclusion criteria. Patients enrolled were administered clostridial collagenase ointment at each regularly scheduled NPWT dressing change. Patients were followed until healing, with visual representations of wound progressi...
- 27 January 2015
- Published by Taylor & Francis in Diabetic Foot & Ankle
- Vol. 6 (1) , 24999
Open AccessUse of collagenase ointment in conjunction with negative pressure wound therapy in the care of diabetic wounds: a case series of six patients
BackgroundDiabetic wounds with additional comorbidities are costly, time intensive, and difficult to heal. Often, multiple modalities may be necessary to achieve wound resolution, relying on the synergistic advantage of each therapy to affect wound healing. The selectivity of Clostridium collagenase is physiologically effective at degrading non-viable collagen fibers while preserving living collagen tissue. Additionally, negative pressure wound therapy (NPWT) has long been used to aid wound healing while concurrently depreciating biological wound burden time.MethodsSix patients were selected from those appearing to our university based limb salvage service. Inclusion criteria included patients with a recurrent mixed fibrotic and granular wound base, in which NPWT was indicated, without exclusion criteria. Patients enrolled were administered clostridial collagenase ointment at each regularly scheduled NPWT dressing change. Patients were followed until healing, with visual representations of wound progressi...
- Open Access
- 22 January 2015
- Published by Taylor & Francis in Diabetic Foot & Ankle
- Vol. 6 (1) , 24972
Reduction of pain via platelet-rich plasma in split-thickness skin graft donor sites: a series of matched pairs
Reduction of pain via platelet-rich plasma in splitthickness skin graft donor sites: a series of matched pairs
- 22 January 2015
- Published by Taylor & Francis in Diabetic Foot & Ankle
- Vol. 6 (1) , 24972
Open AccessReduction of pain via platelet-rich plasma in split-thickness skin graft donor sites: a series of matched pairs
Reduction of pain via platelet-rich plasma in splitthickness skin graft donor sites: a series of matched pairs
- 1 November 2014
- Vol. 63 (11) , 646-56
How to do a 3-minute diabetic foot exam.
This brief exam will help you to quickly detect major risks and prompt you to refer patients to appropriate specialists.
- 1 November 2014
- Vol. 63 (11) , 646-56
How to do a 3-minute diabetic foot exam.
This brief exam will help you to quickly detect major risks and prompt you to refer patients to appropriate specialists.